Our last session of the I Feel Love book club will feature Tactogen's CEO Matt Baggott and Rachel Nuwer on 11/6. We hope to see you there!

Take a listen to Rachel Nuwer interviewing Matt Baggott for Scientific American's "Science, Quickly" series. scientificamerican.com/podcast/episod…

We're hosting a Psychedelic Social in Oakland next Thursday, November 16th. Join us if you are in the Bay Area! eventbrite.com/e/psychedelic-…

The first session of the I Feel Love book club is available for replay. Featuring author Rachel Nuwer and neuroscientist Gül Dölen. youtube.com/watch?v=DY3kpD…

Our Psychedelic Social will be tomorrow from 7-10pm PST at the MeloMelo Kava Lounge in Oakland. Join us! eventbrite.com/e/psychedelic-…

We have uploaded the second session of the I Feel Love book club featuring Rachel Nuwer in conversation with Joseph Ryan McCowan. youtube.com/watch?v=3rSKzP…

Congratulations to the entire @maps_pbc and MAPS teams for a monumental 30 years of work leading to this moment.

"Our goal is to make medicines that are derived from psychedelics that are safer and gentler, more effective and more accessible." Thanks Mercury News for featuring Matt Baggott and Luke Pustejovsky alongside Calyx Law LLP, Boris D Heifets,Olson Lab,Brom Rector mercurynews.com/2023/12/12/new…

“Our goal is to make medicines that are derived from psychedelics that are safer and gentler, more effective and more accessible” said ⁦Matt Baggott⁩ of ⁦Tactogen⁩. ⁦Delix⁩ ⁦Boris D Heifets⁩ ⁦⁦Calyx Law LLP⁩ mercurynews.com/2023/12/12/new…

Thank you DoubleBlind for featuring Matt Baggott with his in-depth analysis of Moxy (5-MeO-MiPT). Tactogen opposed the DEA's proposed ban on Moxy and other tryptamines in 2022. doubleblindmag.com/what-is-moxy/

We're excited to announce that Matt Baggott will be appearing at two events in the coming months. ISRP: February 16-18 in New Orleans. isrpsych.org SXSW: March 8-11 in Austin, Texas. Featuring Tim Schlidt , Julie Holland, MD, and Rachel Nuwer. schedule.sxsw.com/2024/events/PP…

Paper published today co-authored by Matt Baggott. Major points highlight some focus of our work. Key to why we focus on novel entactogens: jpet.aspetjournals.org/content/early/…

Thank you Psychedelic Alpha and team for your work of this psychedelic drug development bullseye chart. This chart features four of Tactogen's molecules in development.

Tactogen Psychedelic Alpha It’s indeed a (yet another) awesome chart. Psychedelic Alpha is quickly becoming the true Bloombergs of all things psychedelic

Join us on Valentine's Day for "Exploring MDMA on Valentine's Day", a fireside chat featuring Matt Baggott, moderated by Joe Hashmall. Glimpse into the future of entactogen research. Hosted by Dragonfly 44 Capital. Event is free, register here: us06web.zoom.us/webinar/regist…

We'd like to extend our congratulations to the Lykos Therapeutics team on the fantastic news that the FDA has accepted their new drug application for MDMA-assisted therapy for PTSD and granted it priority review. Groundbreaking!

"Exploring MDMA on Valentine's Day" is in two days on Feb 14th from 9-10am PST! Join Matt Baggott in the exploration of the science and research behind MDMA. Register with this link: us06web.zoom.us/webinar/regist…

Join us on March 9th at #SXSW24. Matt Baggott will be a panelist for "FDA Approved Love? Exploring MDMA's Psychedelic Journey" alongside Julie Holland, MD, Rachel Nuwer and Tim Schlidt: schedule.sxsw.com/2024/events/PP…

SXSW soon! come see: